A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3

被引:0
作者
Morten Mau-Sørensen
Christian Dittrich
Rodrigo Dienstmann
Ulrik Lassen
Wilfried Büchler
Holger Martinius
Josep Tabernero
机构
[1] Rigshospitalet,Department of Oncology, The Finsen Centre
[2] Kaiser Franz Josef-Spital,Ludwig Boltzmann Institute for Applied Cancer Research (LBI
[3] Vall d’Hebron Hospital,ACR VIEnna) – LB Cluster Translational Oncology, Centre for Oncology and Haematology
[4] Neovii Biotech GmbH,Vall d’Hebron Institute of Oncology
来源
Cancer Chemotherapy and Pharmacology | 2015年 / 75卷
关键词
Catumaxomab; Bispecific antibody; Phase I; EpCAM; CD3; Solid tumor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1065 / 1073
页数:8
相关论文
共 76 条
[1]  
Went P(2004)Frequent EpCAM protein expression in human carcinomas Hum Pathol 35 122-128
[2]  
Lugli A(2006)Frequent high-level expression of the immunotherapeutic target EpCAM in colon, stomach, prostate and lung cancers Br J Cancer 94 128-135
[3]  
Meier S(2004)High EpCAM expression is associated with poor prognosis in node-positive breast cancer Breast Cancer Res Treat 86 207-213
[4]  
Went P(2006)Overexpression of epithelial cell adhesion molecule (EpCAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer Gynecol Oncol 103 483-488
[5]  
Vasei M(1999)The biology of the 17-1A antigen (EpCAM) J Mol Mod 77 699-712
[6]  
Bubendorf L(2003)Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas Cancer Lett 193 25-32
[7]  
Spizzo G(1995)Preferential species-restricted heavy/light chain pairing in rat/mouse quadromas. Implications for a single-step purification of bispecific antibodies J Immunol 155 219-225
[8]  
Went P(1999)Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing J Immunol 163 1246-1252
[9]  
Dirnhofer S(1998)Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens Clin Cancer Res 4 2669-2676
[10]  
Spizzo G(2001)Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (alpha EpCAM x alpha CD3) J Histochem Cytochem 49 911-917